Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion type Assertion NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_head.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion description "[At the fore front of these advances is the discovery that 35%-55% of patients with CIMF harbor mutations in the Janus kinase 2 tyrosine kinase gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_provenance.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion evidence source_evidence_curated NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_provenance.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion SIO_000772 16951397 NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_provenance.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion wasDerivedFrom ctd_human-20150221 NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_provenance.
- NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_assertion wasGeneratedBy ECO_0000218 NP19963.RAkjCEcOKJm67jMjJRZsY6RIk3gru0MeSxRrQcjz05ujs130_provenance.